NeuroPace (NPCE) EBT (2020 - 2026)

NeuroPace's EBT history runs 7 years deep, the most recent figure standing at -$6.5 million for Q1 2026.

• In Q1 2026, EBT changed 0.26% year-over-year to -$6.5 million; the TTM figure through Mar 2026 stood at -$21.0 million (up 15.94% YoY), while the FY2025 annual figure was -$21.0 million, up 23.56% from the prior year.
• EBT was -$6.5 million for Q1 2026 at NeuroPace, down from -$2.7 million in the prior quarter.
• In the past five years, EBT ranged from a high of -$2.7 million in Q4 2025 to a low of -$12.6 million in Q2 2022.
• Historically, EBT has averaged -$7.9 million across 5 years, with a median of -$7.6 million in 2024.
• The sharpest annual moves came in 2022 and 2025: EBT tumbled 101.12% in 2022, then jumped 47.15% in 2025.
• A 5-year view of EBT shows it stood at -$11.0 million in 2022, then soared by 41.23% to -$6.5 million in 2023, then climbed by 20.12% to -$5.2 million in 2024, then surged by 47.15% to -$2.7 million in 2025, then sank by 139.06% to -$6.5 million in 2026.
• The last three EBT figures came in at -$6.5 million (Q1 2026), -$2.7 million (Q4 2025), and -$3.6 million (Q3 2025), per Business Quant data.